Investment15 Aug 2026, 09:31 am
RPG Life Sciences Invests ₹65.68 Cr in Subsidiary RPG Active Pharma
AI Summary
RPG Life Sciences Ltd has announced a significant investment of up to ₹65.68 crore in its wholly-owned subsidiary, RPG Active Pharma Limited (RPGAP), through a rights issue. RPGAP, incorporated on December 24, 2025, is yet to commence operations and has an authorized share capital of ₹7 crore and paid-up capital of ₹1.16 crore. This investment, made via cash consideration, will maintain RPG Life Sciences' 100% shareholding in RPGAP. The transaction falls under related party regulations and is conducted at arm's length. RPGAP belongs to the Pharmaceutical Industry.
Key Highlights
- RPG Life Sciences invests up to ₹65.68 crore in subsidiary RPG Active Pharma.
- Investment is via subscription in a rights issue of equity shares.
- RPGAP is a wholly-owned subsidiary yet to commence operations.
- RPG Life Sciences maintains 100% shareholding post-investment.
- Transaction is a related party transaction at arm's length.
Price Impact
More from RPGLIFE